Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Gastrointestinal Neoplasms × Clear all

Phase

Status

Completed 271 Recruiting 135 Unknown 100 Terminated 54 Active not recruiting 40 Withdrawn 20 Not yet recruiting 20 Enrolling by invitation 4 Available 2 Suspended 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 45 Breast Neoplasms 44 Prostatic Neoplasms 27 Colorectal Neoplasms 26 Glioblastoma 20 Carcinoma, Non-Small-Cell Lung 19 Leukemia, Myeloid, Acute 18 Melanoma 16 Lung Neoplasms 15 Brain Neoplasms 15 Pancreatic Neoplasms 14 Ovarian Neoplasms 14 Neoplasm Metastasis 14 Glioma 14 Stomach Neoplasms 13 Carcinoma, Hepatocellular 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Triple Negative Breast Neoplasms 10 Myelodysplastic Syndromes 10 Multiple Myeloma 9 Lymphoma 9 Head and Neck Neoplasms 9 Carcinoma, Renal Cell 9 Leukemia 7 Hematologic Neoplasms 7 Esophageal Neoplasms 7 Colonic Neoplasms 7 Uterine Cervical Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 6 Endometrial Neoplasms 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05158907 2023-04-19

PROSE

Tata Medical Center

Phase NA Suspended

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡